First Eagle Investment Management, LLC X4 Pharmaceuticals, Inc Transaction History

First Eagle Investment Management, LLC

  • $44.3 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$11.06 - $15.75 $395,173 - $562,747
-35,730 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$12.57 - $21.67 $188,550 - $325,050
15,000 Added 72.36%
35,730 $536,000
Q1 2019

May 13, 2019
BUY
$15.19 - $22.98 $314,888 - $476,375
20,730 New
20,730 $361,000

Others Institutions Holding XFOR

# of Institutions
97
Shares Held
99.6M
Call Options Held
421K
Put Options Held
80.6K
View Full List

About X4 Pharmaceuticals, Inc

XFOR Quotes by TradingView
  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $32.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track This Portfolio

Track First Eagle Investment Management, LLC Portfolio

Follow First Eagle Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Eagle Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Eagle Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email